Challenges for optimal care in onconephrology.
作者信息
Hanna Paul E, Chowdhury Raad, Solhjou Zhabiz, Gupta Shruti, Jhaveri Kenar D
机构信息
Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
出版信息
Nephrol Dial Transplant. 2024 Jan 31;39(2):167-169. doi: 10.1093/ndt/gfad160.
Abstract
摘要
相似文献
1
Challenges for optimal care in onconephrology.
Nephrol Dial Transplant. 2024 Jan 31;39(2):167-169. doi: 10.1093/ndt/gfad160.
2
Onconephrology Fellowship Training: Current Status and Future Outlook.
Kidney360. 2024 Sep 1;5(9):1380-1385. doi: 10.34067/KID.0000000000000495.
3
Onconephrology 2022: An Update.
Kidney360. 2023 Feb 1;4(2):258-271. doi: 10.34067/KID.0001582022. Epub 2022 Dec 9.
4
Onconephrology: The intersections between the kidney and cancer.
CA Cancer J Clin. 2021 Jan;71(1):47-77. doi: 10.3322/caac.21636. Epub 2020 Aug 27.
5
Onconephrology: the need and the emergence of a subspecialty in nephrology.
Kidney Int. 2014 May;85(5):1002-4. doi: 10.1038/ki.2014.29.
6
Opening an onconephrology clinic: recommendations and basic requirements.
Nephrol Dial Transplant. 2018 Sep 1;33(9):1503-1510. doi: 10.1093/ndt/gfy188.
7
Exploring the Present and Imagining the Future Landscape of Onconephrology.
Kidney360. 2024 Sep 1;5(9):1377-1379. doi: 10.34067/KID.0000000000000544. Epub 2024 Aug 26.
8
[Ten Years of Onconephrology].
G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
9
Onconephrology: An Evolving Field.
Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):305-307. doi: 10.14797/mdcj-15-4-305.
10
Onconephrology abstracts and publication trends: time to collaborate.
Clin Kidney J. 2015 Oct;8(5):629-31. doi: 10.1093/ckj/sfv085. Epub 2015 Sep 24.
引用本文的文献
1
Malignancy in Dialysis Patients-How Serious Is the Problem, Especially in Relation to Waiting List Status?
Cancers (Basel). 2025 Aug 26;17(17):2782. doi: 10.3390/cancers17172782.
2
Editorial: Onconephrology: evolving concepts and challenges.
Front Nephrol. 2025 Apr 4;5:1585605. doi: 10.3389/fneph.2025.1585605. eCollection 2025.
本文引用的文献
1
Subspecialty Focus Tracks During Nephrology Fellowship Training.
Am J Kidney Dis. 2023 Dec;82(6):639-643. doi: 10.1053/j.ajkd.2023.05.006. Epub 2023 Jul 27.
2
Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors.
Kidney Int Rep. 2022 Dec 5;8(3):628-641. doi: 10.1016/j.ekir.2022.11.020. eCollection 2023 Mar.
3
Reimagining Nephrology Fellowship Education to Meet the Future Needs of Nephrology: A Report of the American Society of Nephrology Task Force on the Future of Nephrology.
Clin J Am Soc Nephrol. 2023 Jun 1;18(6):816-825. doi: 10.2215/CJN.0000000000000133. Epub 2023 Feb 27.
4
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
5
Current State of the Workforce in Nephrology.
Adv Chronic Kidney Dis. 2020 Jul;27(4):281-290.e1. doi: 10.1053/j.ackd.2020.07.007. Epub 2020 Oct 24.
6
Onconephrology: The intersections between the kidney and cancer.
CA Cancer J Clin. 2021 Jan;71(1):47-77. doi: 10.3322/caac.21636. Epub 2020 Aug 27.
7
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
8
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.
Clin J Am Soc Nephrol. 2008 Mar;3(2):348-54. doi: 10.2215/CJN.02870707. Epub 2008 Jan 30.
Zotero 插件